Friday, July 10, 2026

Drug profile · INN

rizatriptan

rizatriptan (RIXALT) is a serotonin 1b (5-ht1b) receptor agonist. Associated with Alphapharm Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — rizatriptan

Quick answer

rizatriptan (RIXALT) is a serotonin 1b (5-ht1b) receptor agonist. Associated with Alphapharm Pty Ltd.

Key facts

INN rizatriptan
Brand RIXALT
Mechanism Serotonin 1b (5-HT1b) receptor agonist

Mechanism of action

Serotonin 1b (5-HT1b) receptor agonist

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. AXS-07 (MoSEIC meloxicam and rizatriptan) Phase 3 · Axsome Therapeutics · Migraine
  2. AXS-07 (meloxicam-rizatriptan) Phase 3 · Axsome Therapeutics · Migraine
  3. 10mg DS-8500a tablet Phase 2 · Daiichi Sankyo US · Type 2 Diabetes Mellitus

Frequently asked questions

What is rizatriptan?

rizatriptan (RIXALT) is a serotonin 1b (5-ht1b) receptor agonist. Associated with Alphapharm Pty Ltd.

What is the brand name for rizatriptan?

RIXALT is a marketed brand name for rizatriptan. Check FDA Drugs@FDA for the current US label holder and prescribing information.